Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team..

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

2.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team., Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

3.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team., Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

4.

Procainamide depleted tablets not a cause of death.

Griesemer EC.

J Anal Toxicol. 1984 Sep-Oct;8(5):244-5.

PMID:
6503230
5.
6.

Determination of lidocaine in postmortem fluids and tissues.

Liu Y, Griesemer EC, Budd RD, Noguchi TT.

J Chromatogr. 1983 Sep 30;268(2):329-35. No abstract available.

PMID:
6643589
7.

The frequency of deaths resulting from the use of drugs and chemicals in Los Angeles County.

Budd RD, Lindstrom DM, Griesemer EC, Noguchi TT.

Bull Narc. 1983 Jan-Mar;35(1):41-9.

PMID:
6555055
8.

Study of the stability of cocaine and benzoylecgonine, its major metabolite, in blood samples.

Liu Y, Budd RD, Griesemer EC.

J Chromatogr. 1982 Oct 22;248(2):318-20. No abstract available.

PMID:
7174764
9.

Hydromorphone detected in bile following hydrocodone ingestion.

Park JI, Nakamura GR, Griesemer EC, Noguchi TT.

J Forensic Sci. 1982 Jan;27(1):223-4.

PMID:
6178789
10.

Determination of 1-(1-phenylcyclohexyl) pyrrolidine (PHP) in postmortem specimens: a case report.

Nakamura GR, Griesemer EC, Joiner LE, Noguchi TT.

Clin Toxicol. 1979 Apr;14(4):383-8. No abstract available.

PMID:
466980
11.

Drug analyses of skeletonizing remains.

Noguchi TT, Nakamura GR, Griesemer EC.

J Forensic Sci. 1978 Jul;23(3):490-2. No abstract available.

PMID:
744977
12.

Antemortem conversion of codeine to morphine in man.

Nakamura GR, Griesemer EC, Noguchi TT.

J Forensic Sci. 1976 Jul;21(3):518-24.

PMID:
956742
13.

Contour thin-layer chromatography.

Griesemer EC.

J Chromatogr. 1968 Jan 23;32(2):278-96. No abstract available.

PMID:
5651095
14.

A TOXIC HAZARD STUDY OF SELECTED MISSILE PROPELLANTS (1964). TECHN DOCUM REP NO. AMRL-TDR-64-28.

LONGLEY MY, GRIESEMER EC, CULVER BD, NOLE DA, MOSS V.

AMRL TR. 1964 Apr:1-66. No abstract available.

PMID:
14245991
15.

Antagonism of reserpine hypothermia in mice by 3,4-dihydroxyphenylalanine (dopa).

GRIESEMER EC, GASNER LT, CLARK WG.

Proc West Pharmacol Soc. 1962;5:7-8. No abstract available.

PMID:
13950379
16.

"Recovery" responses of hypoxic arterial smooth muscle.

GRIESEMER EC, CORET IA.

J Pharmacol Exp Ther. 1960 Nov;130:294-302. No abstract available.

PMID:
13708563
17.

Abolition of epinephrine inactivating properties of liver by inhibitors of monoamine oxidase.

GRIESEMER EC, WELLS JA.

J Pharmacol Exp Ther. 1956 Mar;116(3):282-6. No abstract available.

PMID:
13307390
18.

Adrenergic blockade by iproniazid.

GRIESEMER EC, DRAGSTEDT CA, WELLS JA, ZELLER EA.

Experientia. 1955 May 15;11(5):182-3. No abstract available.

PMID:
14391277
19.

Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines.

GRIESEMER EC, BARSKY J, DRAGSTEDT CA, WELLS JA, ZELLER EA.

Proc Soc Exp Biol Med. 1953 Dec;84(3):699-701. No abstract available.

PMID:
13134261

Supplemental Content

Loading ...
Support Center